James A. Fornwald
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability, RNA and protein synthesis mechanisms, Monoclonal and Polyclonal Antibodies Research, Chemokine receptors and signaling
Most-Cited Works
- → Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542(2002)647 cited
- → Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules(2006)396 cited
- → Identification of the residues in human CD4 critical for the binding of HIV(1989)355 cited
- → Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)(2002)309 cited
- → The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase(2000)213 cited
- → The complete nucleotide sequence of the chick a-actin gene and its evolutionary relationship to the actin gene family(1982)181 cited
- → Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration(2000)122 cited
- → Two promoters, one inducible and one constitutive, control transcription of the Streptomyces lividans galactose operon.(1987)72 cited
- → Gene organization and structure of the Streptomyces lividans gal operon(1988)69 cited
- → Native Complex Formation between Apolipoprotein E Isoforms and the Alzheimer's Disease Peptide Aβ(1996)55 cited